\select@language {catalan}
\contentsline {section}{\numberline {1}Variabilitat Cl\IeC {\'\i }nica}{2}{section.1}
\contentsline {subsection}{\numberline {1.1}Mesura o determinaci\'o}{2}{subsection.1.1}
\contentsline {subsubsection}{\numberline {1.1.1}Variabilitat premetrol\`ogica}{2}{subsubsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.2}Variabilitat iatrog\`enica}{4}{subsubsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.3}Variabilitat biol\`ogica intraindividual}{4}{subsubsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.4}Variabilitat metrol\`ogica}{5}{subsubsection.1.1.4}
\contentsline {subsubsection}{\numberline {1.1.5}Variabilitat post metrol\`ogica}{5}{subsubsection.1.1.5}
\contentsline {subsubsection}{\numberline {1.1.6}Variabilitat patol\`ogica}{5}{subsubsection.1.1.6}
\contentsline {section}{\numberline {2}Semiologia}{6}{section.2}
\contentsline {subsection}{\numberline {2.1}Valors de refer\`encia}{6}{subsection.2.1}
\contentsline {subsection}{\numberline {2.2}Determinaci\'o de la capacitat discriminant}{6}{subsection.2.2}
\contentsline {section}{\numberline {3}Control de qualitat}{8}{section.3}
\contentsline {subsection}{\numberline {3.1}Normativa aplicable}{8}{subsection.3.1}
\contentsline {subsection}{\numberline {3.2}Control de qualitat}{8}{subsection.3.2}
\contentsline {subsubsection}{\numberline {3.2.1}Control de qualitat intern}{8}{subsubsection.3.2.1}
\contentsline {subsubsection}{\numberline {3.2.2}Control de qualitat extern}{9}{subsubsection.3.2.2}
\contentsline {section}{\numberline {4}Prote\IeC {\@umlaut \i }nes plasm\`atiques}{10}{section.4}
\contentsline {subsection}{\numberline {4.1}Prote\IeC {\@umlaut \i }nes plasm\`atiques de transport}{10}{subsection.4.1}
\contentsline {subsection}{\numberline {4.2}Prote\IeC {\@umlaut \i }nes de fase aguda}{11}{subsection.4.2}
\contentsline {subsection}{\numberline {4.3}Altres prote\IeC {\@umlaut \i }nes}{12}{subsection.4.3}
\contentsline {subsubsection}{\numberline {4.3.1}Immunoglobulines}{12}{subsubsection.4.3.1}
\contentsline {subsubsection}{\numberline {4.3.2}Prote\IeC {\@umlaut \i }nes del complement}{12}{subsubsection.4.3.2}
\contentsline {subsection}{\numberline {4.4}Determinaci\'o de la prote\IeC {\@umlaut \i }na total}{13}{subsection.4.4}
\contentsline {subsection}{\numberline {4.5}Interpretaci\'o cl\IeC {\'\i }nica}{15}{subsection.4.5}
\contentsline {subsection}{\numberline {4.6}Fraccionament de prote\IeC {\@umlaut \i }nes}{15}{subsection.4.6}
\contentsline {subsubsection}{\numberline {4.6.1}Patrons electrofor\`etics an\`omals}{16}{subsubsection.4.6.1}
\contentsline {subsection}{\numberline {4.7}M\`etodes immunol\`ogics per la detecci\'o de prote\IeC {\@umlaut \i }nes}{17}{subsection.4.7}
\contentsline {section}{\numberline {5}Hemost\`asia i coagulaci\'o}{18}{section.5}
\contentsline {subsection}{\numberline {5.1}Introducci\'o}{18}{subsection.5.1}
\contentsline {subsubsection}{\numberline {5.1.1}Hemost\`asia}{18}{subsubsection.5.1.1}
\contentsline {subsubsection}{\numberline {5.1.2}Paper de la c\`el\IeC {\textperiodcentered }lula endotelial}{18}{subsubsection.5.1.2}
\contentsline {subsection}{\numberline {5.2}Hemost\`asia prim\`aria}{19}{subsection.5.2}
\contentsline {subsubsection}{\numberline {5.2.1}Patologies relacionades amb l'hemost\`asia prim\`aria}{20}{subsubsection.5.2.1}
\contentsline {paragraph}{\numberline {5.2.1.1}Malalties heredit\`aries de defici\`encia plaquet\`aria}{21}{paragraph.5.2.1.1}
\contentsline {paragraph}{\numberline {5.2.1.2}Trombocitosi}{22}{paragraph.5.2.1.2}
\contentsline {subsubsection}{\numberline {5.2.2}Tests per avaluar la hemost\`asia prim\`aria}{23}{subsubsection.5.2.2}
\contentsline {paragraph}{\numberline {5.2.2.1}Fragilitat capil\IeC {\textperiodcentered }lar}{23}{paragraph.5.2.2.1}
\contentsline {paragraph}{\numberline {5.2.2.2}Temps de sagnia}{23}{paragraph.5.2.2.2}
\contentsline {paragraph}{\numberline {5.2.2.3}Recompte de plaquetes}{23}{paragraph.5.2.2.3}
\contentsline {paragraph}{\numberline {5.2.2.4}Mida de les plaquetes}{23}{paragraph.5.2.2.4}
\contentsline {paragraph}{\numberline {5.2.2.5}Temps d'agregaci\'o plaquet\`aria}{24}{paragraph.5.2.2.5}
\contentsline {subsection}{\numberline {5.3}Hemost\`asia secund\`aria/Coagulaci\'o proteica}{24}{subsection.5.3}
\contentsline {subsubsection}{\numberline {5.3.1}Prote\IeC {\@umlaut \i }nes i factors de coagulaci\'o}{24}{subsubsection.5.3.1}
\contentsline {subsubsection}{\numberline {5.3.2}Cascada de coagulaci\'o}{25}{subsubsection.5.3.2}
\contentsline {subsubsection}{\numberline {5.3.3}Tipus de factors de coagulaci\'o i mecanismes d'activaci\'o}{26}{subsubsection.5.3.3}
\contentsline {paragraph}{\numberline {5.3.3.1}Vitamina K}{26}{paragraph.5.3.3.1}
\contentsline {subsubsection}{\numberline {5.3.4}Visi\'o actual de la coagulaci\'o}{27}{subsubsection.5.3.4}
\contentsline {subsubsection}{\numberline {5.3.5}Formaci\'o del co\`agul proteic}{28}{subsubsection.5.3.5}
\contentsline {subsubsection}{\numberline {5.3.6}Inhibici\'o fisiol\`ogica de la coagulaci\'o}{28}{subsubsection.5.3.6}
\contentsline {subsection}{\numberline {5.4}Fibrin\`olisi}{28}{subsection.5.4}
\contentsline {subsubsection}{\numberline {5.4.1}Patologies relacionades amb la coagulaci\'o i la fibrin\`olisi}{29}{subsubsection.5.4.1}
\contentsline {paragraph}{\numberline {5.4.1.1}D\`eficits cong\`enits en factors de coagulaci\'o. Hemof\IeC {\'\i }lies}{29}{paragraph.5.4.1.1}
\contentsline {paragraph}{\numberline {5.4.1.2}Hipercoagulabilitat}{29}{paragraph.5.4.1.2}
\contentsline {subsubsection}{\numberline {5.4.2}Tests per avaluar la coagulaci\'o i la fibrin\`olisi}{31}{subsubsection.5.4.2}
\contentsline {subsubsection}{\numberline {5.4.3}Tractament antitromb\`otic}{32}{subsubsection.5.4.3}
\contentsline {section}{\numberline {6}Hemoglobina i ferro}{33}{section.6}
\contentsline {subsection}{\numberline {6.1}La hemoglobina}{33}{subsection.6.1}
\contentsline {subsubsection}{\numberline {6.1.1}Estructura}{34}{subsubsection.6.1.1}
\contentsline {subsection}{\numberline {6.2}Trastorns deguts a reaccions de l'hemoglobina}{34}{subsection.6.2}
\contentsline {subsection}{\numberline {6.3}Trastorns a la s\IeC {\'\i }ntesi de la globina}{35}{subsection.6.3}
\contentsline {subsubsection}{\numberline {6.3.1}Hemoglobinopaties estructurals}{35}{subsubsection.6.3.1}
\contentsline {paragraph}{\numberline {6.3.1.1}Hemoglobina S. An\`emia drepanoc\IeC {\'\i }tica}{35}{paragraph.6.3.1.1}
\contentsline {paragraph}{\numberline {6.3.1.2}Hemoglobinopaties inestables}{36}{paragraph.6.3.1.2}
\contentsline {paragraph}{\numberline {6.3.1.3}Eritrocitosis}{36}{paragraph.6.3.1.3}
\contentsline {paragraph}{\numberline {6.3.1.4}Metaglobin\`emia}{36}{paragraph.6.3.1.4}
\contentsline {subsubsection}{\numberline {6.3.2}Talass\`emies}{37}{subsubsection.6.3.2}
\contentsline {paragraph}{\numberline {6.3.2.1}$\beta $-Talass\`emies}{37}{paragraph.6.3.2.1}
\contentsline {paragraph}{\numberline {6.3.2.2}$\alpha $-Talass\`emies}{37}{paragraph.6.3.2.2}
\contentsline {subsection}{\numberline {6.4}Desordres de la s\IeC {\'\i }ntesi del grup hemo}{38}{subsection.6.4}
\contentsline {subsubsection}{\numberline {6.4.1}Porf\IeC {\'\i }ries}{40}{subsubsection.6.4.1}
\contentsline {paragraph}{\numberline {6.4.1.1}Porf\IeC {\'\i }rires agudes}{41}{paragraph.6.4.1.1}
\contentsline {subparagraph}{\numberline {6.4.1.1.1}Porf\IeC {\'\i }ria aguda intermitent}{41}{subparagraph.6.4.1.1.1}
\contentsline {subparagraph}{\numberline {6.4.1.1.2}Coproporf\IeC {\'\i }ria heredit\`aria}{41}{subparagraph.6.4.1.1.2}
\contentsline {subparagraph}{\numberline {6.4.1.1.3}Porf\IeC {\'\i }ria variegata}{41}{subparagraph.6.4.1.1.3}
\contentsline {paragraph}{\numberline {6.4.1.2}Porf\IeC {\'\i }ries no agudes}{41}{paragraph.6.4.1.2}
\contentsline {subparagraph}{\numberline {6.4.1.2.1}Porf\IeC {\'\i }ria hep\`atica-cut\`ania (hepatocut\`ania)}{41}{subparagraph.6.4.1.2.1}
\contentsline {subparagraph}{\numberline {6.4.1.2.2}Protoporf\IeC {\'\i }ria eritrohep\`atica (eritropoi\`etica)}{42}{subparagraph.6.4.1.2.2}
\contentsline {subparagraph}{\numberline {6.4.1.2.3}Protoporf\IeC {\'\i }ria eritropoi\`etica cong\`enita}{42}{subparagraph.6.4.1.2.3}
\contentsline {subparagraph}{\numberline {6.4.1.2.4}Intoxicaci\'o per plom}{42}{subparagraph.6.4.1.2.4}
\contentsline {subsection}{\numberline {6.5}Alteracions del metabolisme del ferro}{44}{subsection.6.5}
\contentsline {subsubsection}{\numberline {6.5.1}An\`emies megalobl\`astiques}{46}{subsubsection.6.5.1}
\contentsline {paragraph}{\numberline {6.5.1.1}An\`alisi bioqu\IeC {\'\i }mic}{46}{paragraph.6.5.1.1}
\contentsline {paragraph}{\numberline {6.5.1.2}Prova de Schilling}{47}{paragraph.6.5.1.2}
\contentsline {subsubsection}{\numberline {6.5.2}An\`emies hemol\IeC {\'\i }tiques}{47}{subsubsection.6.5.2}
\contentsline {paragraph}{\numberline {6.5.2.1}An\`emies hemol\IeC {\'\i }tiques degudes a d\`eficits enzim\`atics}{48}{paragraph.6.5.2.1}
\contentsline {subparagraph}{\numberline {6.5.2.1.1}D\`eficit de glucosa-6-fosfat deshidrogenasa}{48}{subparagraph.6.5.2.1.1}
\contentsline {subparagraph}{\numberline {6.5.2.1.2}D\`eficit de piruvat quinasa}{48}{subparagraph.6.5.2.1.2}
\contentsline {paragraph}{\numberline {6.5.2.2}An\`emies hemol\IeC {\'\i }tiques autoimmunes}{49}{paragraph.6.5.2.2}
\contentsline {subparagraph}{\numberline {6.5.2.2.1}An\`emia hemol\IeC {\'\i }tica amb anticossos calents}{49}{subparagraph.6.5.2.2.1}
\contentsline {subparagraph}{\numberline {6.5.2.2.2}An\`emia hemol\IeC {\'\i }tica amb anticossos freds}{49}{subparagraph.6.5.2.2.2}
\contentsline {subparagraph}{\numberline {6.5.2.2.3}An\`emia hemol\IeC {\'\i }tica provocada per f\`armacs}{49}{subparagraph.6.5.2.2.3}
\contentsline {subsection}{\numberline {6.6}Metabolisme del ferro}{50}{subsection.6.6}
\contentsline {subsubsection}{\numberline {6.6.1}Alteracions del metabolisme del ferro}{50}{subsubsection.6.6.1}
\contentsline {subsubsection}{\numberline {6.6.2}An\`emia ferrop\`enica}{51}{subsubsection.6.6.2}
\contentsline {subsubsection}{\numberline {6.6.3}An\`emia siderobl\`astica}{53}{subsubsection.6.6.3}
\contentsline {subsubsection}{\numberline {6.6.4}Hemocromatosis}{53}{subsubsection.6.6.4}
\contentsline {section}{\numberline {7}Enzimologia cl\IeC {\'\i }nica}{54}{section.7}
\contentsline {subsection}{\numberline {7.1}Enzims}{54}{subsection.7.1}
\contentsline {subsubsection}{\numberline {7.1.1}Lesi\'o cel\IeC {\textperiodcentered }lular}{54}{subsubsection.7.1.1}
\contentsline {subsubsection}{\numberline {7.1.2}Mesura de la concentraci\'o dels enzims}{55}{subsubsection.7.1.2}
\contentsline {subsubsection}{\numberline {7.1.3}Distribuci\'o cel\IeC {\textperiodcentered }lular dels enzims}{55}{subsubsection.7.1.3}
\contentsline {subsubsection}{\numberline {7.1.4}Inter\`es diagn\`ostic dels enzims}{56}{subsubsection.7.1.4}
\contentsline {subsection}{\numberline {7.2}Estrat\`egies bioqu\IeC {\'\i }miques per l'estudi cl\IeC {\'\i }nic del metabolisme}{56}{subsection.7.2}
\contentsline {subsubsection}{\numberline {7.2.1}Cin\`etica de les reaccions enzim\`atiques monosubstrat}{57}{subsubsection.7.2.1}
\contentsline {subsubsection}{\numberline {7.2.2}Procediments per a mesurar la velocitat de transformaci\'o}{57}{subsubsection.7.2.2}
\contentsline {subsubsection}{\numberline {7.2.3}Aplicaci\'o de t\`ecniques enzim\`atiques combinades}{57}{subsubsection.7.2.3}
\contentsline {paragraph}{\numberline {7.2.3.1}Determinaci\'o de l'aspartat aminotransferasa (GOT)}{58}{paragraph.7.2.3.1}
\contentsline {subsubsection}{\numberline {7.2.4}Procediment general d'an\`alisi per espectrofotometria visible o UV}{58}{subsubsection.7.2.4}
\contentsline {subsection}{\numberline {7.3}Enzims marcadors habituals en enzimologia cl\IeC {\'\i }nica}{59}{subsection.7.3}
\contentsline {subsubsection}{\numberline {7.3.1}Pancreatitis}{60}{subsubsection.7.3.1}
\contentsline {paragraph}{\numberline {7.3.1.1}$\alpha $-amilasa}{60}{paragraph.7.3.1.1}
\contentsline {subsubsection}{\numberline {7.3.2}Fosfatasa \`acids. Carcinoma de pr\`ostata}{61}{subsubsection.7.3.2}
\contentsline {subsubsection}{\numberline {7.3.3}Marcadors hep\`atics}{61}{subsubsection.7.3.3}
\contentsline {paragraph}{\numberline {7.3.3.1}$\gamma $-glutamil transpeptidasa}{61}{paragraph.7.3.3.1}
\contentsline {paragraph}{\numberline {7.3.3.2}Fosfatasa alcalina}{61}{paragraph.7.3.3.2}
\contentsline {subsubsection}{\numberline {7.3.4}Infart de miocardi}{64}{subsubsection.7.3.4}
\contentsline {paragraph}{\numberline {7.3.4.1}Creatina quinasa}{64}{paragraph.7.3.4.1}
\contentsline {paragraph}{\numberline {7.3.4.2}Lactat deshidrogenasa}{65}{paragraph.7.3.4.2}
\contentsline {paragraph}{\numberline {7.3.4.3}Transaminases}{66}{paragraph.7.3.4.3}
\contentsline {paragraph}{\numberline {7.3.4.4}Marcadors no enzim\`atics}{66}{paragraph.7.3.4.4}
\contentsline {section}{\numberline {8}Disfuncions del metabolisme gluc\IeC {\'\i }dic}{68}{section.8}
\contentsline {subsection}{\numberline {8.1}Regulaci\'o de la concentraci\'o de la glucosa sangu\IeC {\'\i }nia}{68}{subsection.8.1}
\contentsline {subsection}{\numberline {8.2}Hipergluc\`emies}{69}{subsection.8.2}
\contentsline {subsubsection}{\numberline {8.2.1}Alteracions metab\`oliques}{70}{subsubsection.8.2.1}
\contentsline {subsubsection}{\numberline {8.2.2}Complicacions}{71}{subsubsection.8.2.2}
\contentsline {subsection}{\numberline {8.3}Par\`ametres cl\IeC {\'\i }nics}{72}{subsection.8.3}
\contentsline {subsubsection}{\numberline {8.3.1}Glucosa}{72}{subsubsection.8.3.1}
\contentsline {subsubsection}{\numberline {8.3.2}Sobrec\`arrega oral de glucosa (SOG)}{72}{subsubsection.8.3.2}
\contentsline {subsubsection}{\numberline {8.3.3}Insulina}{73}{subsubsection.8.3.3}
\contentsline {subsubsection}{\numberline {8.3.4}Glicohemoglobines}{74}{subsubsection.8.3.4}
\contentsline {subsubsection}{\numberline {8.3.5}Fructosamines}{75}{subsubsection.8.3.5}
\contentsline {subsubsection}{\numberline {8.3.6}Microalbumin\'uria}{75}{subsubsection.8.3.6}
\contentsline {subsubsection}{\numberline {8.3.7}Cossos cet\`onics}{75}{subsubsection.8.3.7}
\contentsline {subsection}{\numberline {8.4}Hipogluc\`emies}{76}{subsection.8.4}
\contentsline {subsubsection}{\numberline {8.4.1}Fisiol\`ogica}{76}{subsubsection.8.4.1}
\contentsline {subsubsection}{\numberline {8.4.2}Patol\`ogiques}{76}{subsubsection.8.4.2}
\contentsline {subsection}{\numberline {8.5}Intoler\`ancies}{77}{subsection.8.5}
\contentsline {section}{\numberline {9}Disfuncions del metabolisme lip\IeC {\'\i }dic}{78}{section.9}
\contentsline {subsection}{\numberline {9.1}Conceptes generals}{78}{subsection.9.1}
\contentsline {subsubsection}{\numberline {9.1.1}Tipus de lipoprote\IeC {\@umlaut \i }nes, composici\'o i estructura}{78}{subsubsection.9.1.1}
\contentsline {subsubsection}{\numberline {9.1.2}Metabolisme de les lipoprote\IeC {\@umlaut \i }nes}{79}{subsubsection.9.1.2}
\contentsline {paragraph}{\numberline {9.1.2.1}Via ex\`ogena}{80}{paragraph.9.1.2.1}
\contentsline {paragraph}{\numberline {9.1.2.2}Via end\`ogena}{80}{paragraph.9.1.2.2}
\contentsline {paragraph}{\numberline {9.1.2.3}Transport revers de colesterol}{81}{paragraph.9.1.2.3}
\contentsline {subsection}{\numberline {9.2}Par\`ametres anal\IeC {\'\i }tics}{82}{subsection.9.2}
\contentsline {subsubsection}{\numberline {9.2.1}Aterosclerosi}{82}{subsubsection.9.2.1}
\contentsline {subsubsection}{\numberline {9.2.2}Dislip\`emia}{83}{subsubsection.9.2.2}
\contentsline {subsubsection}{\numberline {9.2.3}Lipoprote\IeC {\@umlaut \i }nes}{85}{subsubsection.9.2.3}
\contentsline {subsubsection}{\numberline {9.2.4}Colesterol}{85}{subsubsection.9.2.4}
\contentsline {subsubsection}{\numberline {9.2.5}Triacilglicerols}{85}{subsubsection.9.2.5}
\contentsline {subsection}{\numberline {9.3}Dislip\`emies}{86}{subsection.9.3}
\contentsline {subsubsection}{\numberline {9.3.1}Hiperlipoprote\IeC {\@umlaut \i }n\`emies prim\`aries}{86}{subsubsection.9.3.1}
\contentsline {subsubsection}{\numberline {9.3.2}Hiperlipoprote\IeC {\@umlaut \i }n\`emies secund\`aries}{87}{subsubsection.9.3.2}
\contentsline {subsubsection}{\numberline {9.3.3}Hipolipoprote\IeC {\@umlaut \i }n\`emies}{87}{subsubsection.9.3.3}
\contentsline {subsubsection}{\numberline {9.3.4}Tractament}{88}{subsubsection.9.3.4}
\contentsfinish 
